A Placebo-Controlled, Double-blind, Randomized Trial of an Extract of Ginkgo Biloba for Dementia
- 22 October 1997
- journal article
- research article
- Published by American Medical Association (AMA) in JAMA
- Vol. 278 (16) , 1327-1332
- https://doi.org/10.1001/jama.1997.03550160047037
Abstract
Research from JAMA — A Placebo-Controlled, Double-blind, Randomized Trial of an Extract of Ginkgo Biloba for DementiaThis publication has 15 references indexed in Scilit:
- Recent Advances in the Diagnosis of Dementia in Old AgePublished by S. Karger AG ,2015
- Mini-Mental-StateZeitschrift für Gerontopsychologie & -psychiatrie, 2009
- Proof of Efficacy of the Ginkgo Biloba Special Extract EGb 761 in Outpatients Suffering from Mild to Moderate Primary Degenerative Dementia of the Alzheimer Type or Multi-infarct DementiaPharmacopsychiatry, 1996
- Hydrogen peroxide mediates amyloid β protein toxicityCell, 1994
- The efficacy of EGb 761 in patients with senile dementia of the alzheimer type, a double‐blind, placebo‐controlled study on different levels of investigationHuman Psychopharmacology: Clinical and Experimental, 1994
- Myricetin and quercetin, the flavonoid constituents ofGinkgo biloba extract, greatly reduce oxidative metabolism in both resting and Ca2+-loaded brain neuronsBrain Research, 1994
- Ginkgo biloba for cerebral insufficiency.British Journal of Clinical Pharmacology, 1992
- The Application of the Principle of Intention–to–Treat to the Analysis of Clinical TrialsDrug Information Journal, 1991
- The prevalence of dementiaAlzheimer Disease & Associated Disorders, 1988
- Limits of the ‘Mini-Mental State’ as a screening test for dementia and delirium among hospital patientsPsychological Medicine, 1982